Dalbavancin

A Prospective Trial of Dalbavancin-Based Prophylaxis in Children and Adolescents With High-Risk Leukemia

DOTS: Dalbavancin as an Option for Treatment of Staphylococcus Aureus Bacteremia

Dalbavancin for the Treatment of Acute Bacterial Skin and Skin Structure Infections in Children, Known or Suspected to be Caused by Susceptible Gram-positive Organisms, Including MRSA

Prevention and Treatment of Frostbite Infection With Antimicrobial Pharmacokinetic Analysis

Evaluation of Intravenous Dalbavancin for Peritonitis

Efficacy of Dalbavancin in Osteoarticular Infections Associated With Hip and Knee Replacements

Substance Use Disorder (SUD)-Associated Infections' Treatment With Dalbavancin ENabling OUtpatient Transition

Dalbavancin For The Treatment of Gram Positive Osteoarticular Infections

Dalbavancin Outpatient Pilot

Hospital Avoidance Strategies for ABSSSI

Dalbavancin Real-life Utilization in Diabetic Patients Suffering From Infections (DALBADIA)

Efficacy and Safety of Dalbavancin Compared to Standard of Care Antibiotic Therapy for the Completion of Treatment of Patients With Complicated Bacteremia or Infective Endocarditis

Study Evaluate the PK Profile of Dalbavancin in Infants and Neonates Patients With Known or Suspected Bacterial Infection

Evaluation of a New Critical Pathway for Treatment of Acute Bacterial Skin and Skin Structure Infections (ABSSSI)

Development of a New Critical Pathway for Treatment of Acute Bacterial Skin and Skin Structure Infections (ABSSSI)

Study on the Safety and Efficacy of Dalbavancin Versus Active Comparator in Adult Participants With Osteomyelitis

Single Dose vs. Two Dose Regimen of Dalbavancin for the Treatment of Acute Bacterial Skin and Skin Structure Infections

Safety and Efficacy of Dalbavancin Versus Active Comparator in Adult Patients With Osteomyelitis

Dalbavancin vs Comparator in Pediatric Subjects With Acute Hematogenous Osteomyelitis

A P3 Comparator Trial in Community Acquired Bacterial Pneumonia